Speaker Profile

BIOGRAPHY

Doaa Rady is a highly experienced regulatory professional who has dedicated her career to
advancing the quality, safety, and efficacy of biological products. With more than 14 years of
experience in the regulation of vaccines and biologicals, she is recognized as a leading voice
in regulatory system strengthening at national, regional, and global levels.
She began her career at the National Organization for Research and Control of Biologics and
later assumed key leadership roles within the Egyptian Drug Authority (EDA), including team
leader for Egypt’s risk-based lot release policy and manager of the lot release administration.
She was instrumental in achieving WHO maturity level 3 (ML3) for the lot release function in
Egypt.
In recognition of her expertise, Doaa joined the World Health Organization Headquarters
(WHO/HQ) as a Rotational Technical Officer in the Regulation and Safety (REG) Unit,
representing EDA and the North Africa region. In this role, she contributes to global guidance
development, regulatory convergence initiatives, and capacity-building activities that enhance
reliance and harmonization across regulatory authorities.
Currently, she serves as Chairperson of the African Medicines Quality Forum (AMQF)
Vaccine Subcommittee and has recently been appointed as one of Africa CDC’s instructors for
regulatory affairs, reflecting her commitment to building continental regulatory capacity.
Doaa holds degrees in Pharmaceutical Sciences, Microbiology & Immunology, and
Pharmacoeconomics and Health Technology Assessment. She combines her technical
expertise with strong leadership and a collaborative vision, making her a respected figure in
shaping the future of regulatory science in Africa and beyond.